NeurAxis grants fully vested stock to three non-employee directors; initiates quarterly equity compensation

Neuraxis, INC

Three non-employee directors (Ferge, Keyser, Watkins) granted fully vested shares for services through March 31, 2024.
Shares valued at $2.78 per share (closing price June 28, 2024); first issuance under 2022 Plan post-IPO.
Future quarterly grants: each director to receive $12,500 in stock per quarter, totaling $50,000 annual equity compensation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.